Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 3

The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients

Pages
1115–1122
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MTV and TLG values are important parameters, which can efficiently be used to predict TNR.Key words: Pediatric osteosarcoma, positron emission tomography, tumor necrosis rate

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The aim of this study was to investigate the contribution of fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in staging of pediatric osteosarcoma patients and also to evaluate the ability of metabolic parameters from the primary tumor to predict tumor necrosis rate (TNR).
📊
Key Findings & Data:Material and methods: F-18 FDG-PET/CT imaging was performed in staging 37 pediatric osteosarcoma patients.
💡
Conclusion & Impact:MTV and TLG values are important parameters, which can efficiently be used to predict TNR.Key words: Pediatric osteosarcoma, positron emission tomography, tumor necrosis rate
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The aim of this study was to investigate the contribution of fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in staging of pediatric osteosarcoma patients and also to evaluate the ability of metabolic parameters from the primary tumor to predict tumor necrosis rate (TNR). Material and methods: F-18 FDG-PET/CT imaging was performed in staging 37 pediatric osteosarcoma patients. The metabolic parameters SUVmax (maximum standardised uptake value), MTV (metabolic tumour volume), and TLG (total lesion glycolysis) were measured from the primary tumor. TNR level of the primary tumor was histopathologically measured after standard neoadjuvant chemotherapy treatment. The contribution of F-18 FDG-PET/CT to staging of pediatric osteosarcoma patients and the accuracy of metabolic parameters of the primary tumor to predict TNR were analized by regression analysis. Results: MTV and TLG of the primary tumor were found to efficiently predict histopathologic TNR, whereas SUVmax was not (P = 0.012, P = 0.027, P = 0.25, respectively). Also 5 of 12 patients (41.6%) who were initially defined as localised osteosarcoma were upstaged in consequence of staging F-18 FDG-PET/CT findings. Conclusion: F-18 FDG-PET/CT staging in pediatric osteosarcoma patients can effectively distinguish metastatic-localised disease. MTV and TLG values are important parameters, which can efficiently be used to predict TNR.Key words: Pediatric osteosarcoma, positron emission tomography, tumor necrosis rate

🔖

Cite This Article

FİDAN, A. K., UÇMAK, G., DEMİREL, B. B., EFETÜRK, H., ÖZTÜRK, İ., ŞENLİK, S. D., AKKAŞ, B. E., İLHAN, İ. E. (2022). The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 3, 1115–1122. https://ajindex.com/articles/609477

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S et al. Pediatric bone sarcoma: diagnostic performance of 18F-FDG PET/ CT versus conventional imaging for initial staging and followup. American Journal of Roentgenology 2015
  2. 204 (1): 153- 160. doi: 10.2214/AJR.14.12932 2. Quartuccio N, Treglia G, Salsano M, Mattoli MV, Muoio B et al. The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma. Radiology and Oncology 2013
  3. 47 (2): 97-102. doi: 10.2478/raon-2013-0017 3. Coffin CM, Lowichik A, Zhou H. Treatment effects in pediatric soft tissue and bone tumors. American Journal of Clinical Pathology 2005
  4. 123 (1): 75-90. doi: 10.1309/h0d4vd760nh6n1r6 4. Costelloe CM, Chuang HH, Madewell JE. FDG PET/CT of primary bone tumors. American Journal of Roentgenology 2014
  5. 202 (6): W521-W531. doi: 10.2214/AJR.13.11833 5. Byun BH, Kong CB, Lim I, Kim BI, Choi CW et al. Comparison of (18) F-FDG PET/CT and (99 m) Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma. Skeletal Radiology 2013
  6. 42 (12): 1673-1681. doi: 10.1007/s00256-013- 1714-4 6. Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR et al. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. Journal of Nuclear Medicine 2009
  7. 50 (3): 340-347. doi: 10.2967/ jnumed.108.058461 7. Faisham WI, Mat Saad AZ, Alsaigh LN, Nor Azman MZ, Kamarul MI et al. Prognostic factors and survival rate of osteosarcoma: A single‐institution study. Asia-Pacific Journal of Clinical Oncology 2017
  8. 13 (2): e104-e110. doi: 10.1111/ ajco.12346 8. Joo MW, Kang YK, Yoo CY, Cha SH, Chung YG. Prognostic significance of chemotherapy-induced necrosis in osteosarcoma patients receiving pasteurized autografts. PLoS ONE 2017
  9. 12 (2): e0172155. doi: 10.1371/journal. pone.0172155 9. Whelan J, Jinks R, McTiernan A, Sydes M, Hook J et al. Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Annals of Oncology 2012
  10. 23 (6): 1607-1616. doi: 10.1093/annonc/ mdr491 10. National Comprehensive Cancer Network (2020). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Bone Cancer Version 1.2020: 20 [online]. Website: https://www.nccn.org/professionals/physician_gls/pdf/bone. pdf [accessed 08 12 2019]. 11. Völker T, Denecke T, Steffen I, Misch D, Schönberger S et al. Positron emission tom